CORMEDIX INC.: 10-Q filed 2022-11-10

Name: CORMEDIX INC.: 10-Q filed 2022-11-10
Creator: CORMEDIX INC.

What CORMEDIX INC. reported in its quarterly report filed 2022-11-10 (fiscal Q3 2022): 43 published measures, 124 facts as tagged in accession 0001213900-22-070834.

This filing

Form: 10-Q (quarterly report)
Filed: 2022-11-10
Fiscal period: fiscal Q3 2022
Accession: 0001213900-22-070834 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CORMEDIX INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2022-09-30	62,076,932	USD
At 2021-12-31	68,945,576	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2022-09-30	5,764,846	USD
At 2021-12-31	6,147,509	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2022-09-30	56,312,086	USD
At 2022-06-30	61,738,740	USD
At 2021-12-31	62,798,067	USD
At 2021-09-30	69,344,181	USD
At 2021-06-30	76,869,545	USD
At 2020-12-31	44,223,012	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit	Days
At 2022-09-30	43,254,116	USD
At 2021-12-31	53,317,405	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	-6,853,721	USD	92
2022-01-01 to 2022-09-30	-21,492,754	USD	273
2021-07-01 to 2021-09-30	-8,569,366	USD	92
2021-01-01 to 2021-09-30	-20,419,239	USD	273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2022-01-01 to 2022-09-30	-18,201,893	USD	273
2021-01-01 to 2021-09-30	-15,285,863	USD	273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2022-01-01 to 2022-09-30	90,605	USD	273
2021-01-01 to 2021-09-30	796,568	USD	273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	6,817	USD	92
2022-01-01 to 2022-09-30	35,706	USD	273
2021-07-01 to 2021-09-30	38,088	USD	92
2021-01-01 to 2021-09-30	134,539	USD	273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2022-01-01 to 2022-09-30	11,852,662	USD	273
2021-01-01 to 2021-09-30	41,757,551	USD	273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2022-01-01 to 2022-09-30	-3,707,503	USD	273
2021-01-01 to 2021-09-30	-2,005,711	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2022-09-30	-267,151,835	USD
At 2021-12-31	-245,659,081	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	41,183,585	shares	92
2022-01-01 to 2022-09-30	39,741,555	shares	273
2021-07-01 to 2021-09-30	38,113,514	shares	92
2021-01-01 to 2021-09-30	37,515,298	shares	273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	41,183,585	shares	92
2022-01-01 to 2022-09-30	39,741,555	shares	273
2021-07-01 to 2021-09-30	38,113,514	shares	92
2021-01-01 to 2021-09-30	37,515,298	shares	273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	-0.17	USD/shares	92
2022-01-01 to 2022-09-30	-0.54	USD/shares	273
2021-07-01 to 2021-09-30	-0.22	USD/shares	92
2021-01-01 to 2021-09-30	-0.54	USD/shares	273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	-0.17	USD/shares	92
2022-01-01 to 2022-09-30	-0.54	USD/shares	273
2021-07-01 to 2021-09-30	-0.22	USD/shares	92
2021-01-01 to 2021-09-30	-0.54	USD/shares	273

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2022-01-01 to 2022-09-30	-585,617	USD	273
2021-01-01 to 2021-09-30	-1,250,186	USD	273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2022-09-30	1,503,439	USD
At 2021-12-31	1,474,937	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2022-01-01 to 2022-09-30	3,195,469	USD	273
2021-01-01 to 2021-09-30	3,789,361	USD	273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	-6,961,934	USD	92
2022-01-01 to 2022-09-30	-22,234,740	USD	273
2021-07-01 to 2021-09-30	-8,564,919	USD	92
2021-01-01 to 2021-09-30	-21,657,664	USD	273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2022-09-30	59,664,234	USD
At 2021-12-31	66,468,829	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	8,776	USD	92
2022-01-01 to 2022-09-30	17,740	USD	273
2021-07-01 to 2021-09-30	5,381	USD	92
2021-01-01 to 2021-09-30	10,565	USD	273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2022-09-30	5,061,899	USD
At 2021-12-31	5,345,076	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2022-09-30	1,767,407	USD
At 2021-12-31	2,209,552	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	6,967,282	USD	92
2022-01-01 to 2022-09-30	22,267,118	USD	273
2021-07-01 to 2021-09-30	8,577,841	USD	92
2021-01-01 to 2021-09-30	21,691,272	USD	273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2022-09-30	269	USD
At 2021-12-31	3,008	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	5,348	USD	92
2022-01-01 to 2022-09-30	32,378	USD	273
2021-07-01 to 2021-09-30	12,922	USD	92
2021-01-01 to 2021-09-30	33,608	USD	273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	1,469	USD	92
2022-01-01 to 2022-09-30	3,328	USD	273
2021-07-01 to 2021-09-30	25,166	USD	92
2021-01-01 to 2021-09-30	100,931	USD	273

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	4,628,014	USD	92
2022-01-01 to 2022-09-30	14,430,791	USD	273
2021-07-01 to 2021-09-30	3,836,613	USD	92
2021-01-01 to 2021-09-30	11,793,509	USD	273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	2,339,268	USD	92
2022-01-01 to 2022-09-30	7,836,327	USD	273
2021-07-01 to 2021-09-30	4,741,228	USD	92
2021-01-01 to 2021-09-30	9,897,763	USD	273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2022-09-30	41,208,210	shares
At 2021-12-31	38,086,437	shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

Period	Value	Unit
At 2022-09-30	43,470,079	USD
At 2021-12-31	53,551,277	USD
At 2021-09-30	66,552,961	USD
At 2020-12-31	42,096,783	USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2022-09-30	323,376,759	USD
At 2021-12-31	308,331,750	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2022-09-30	45,772	USD
At 2021-12-31	87,130	USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

Period	Value	Unit	Days
At 2022-09-30	806,946	USD
At 2021-12-31	899,505	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2022-09-30	3,163,429	USD
At 2021-12-31	3,014,156	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2022-09-30	530,852	USD
At 2021-12-31	770,485	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	-6,853,721	USD	92
2022-01-01 to 2022-09-30	-22,078,371	USD	273
2021-07-01 to 2021-09-30	-8,569,366	USD	92
2021-01-01 to 2021-09-30	-21,669,425	USD	273

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	-6,847,468	USD	92
2022-01-01 to 2022-09-30	-21,534,112	USD	273
2021-07-01 to 2021-09-30	-8,573,045	USD	92
2021-01-01 to 2021-09-30	-20,425,743	USD	273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2022-01-01 to 2022-09-30	62,102	USD	273
2021-01-01 to 2021-09-30	41,843	USD	273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	108,213	USD	92
2022-01-01 to 2022-09-30	156,369	USD	273
2021-07-01 to 2021-09-30	-4,447	USD	92
2021-01-01 to 2021-09-30	-11,761	USD	273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

Period	Value	Unit	Days
2022-01-01 to 2022-09-30	17,740	USD	273
2021-01-01 to 2021-09-30	10,565	USD	273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2022-01-01 to 2022-09-30	11,724,037	USD	273
2021-01-01 to 2021-09-30	41,455,630	USD	273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2022-01-01 to 2022-09-30	-2,739	USD	273
2021-01-01 to 2021-09-30	-99,546	USD	273

Inspect the source

Entity: CORMEDIX INC. / CIK 0001410098
Captured: 2026-09-20T08:01:45.168Z
SEC response SHA-256: b75757faacc84388fbe591a3ec2593969ffefe3c9ea86056a188a6fcb0c2f8bb

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001410098.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))